20,000 Shares in OrthoPediatrics Corp. $KIDS Acquired by Birchview Capital LP

Key Points

• Birchview Capital LP has acquired 20,000 shares of OrthoPediatrics Corp. (NASDAQ: KIDS), valued at approximately $493,000, representing about 0.08% of the company's stock.
• OrthoPediatrics reported (-$0.11) earnings per share for the last quarter, exceeding analyst expectations of (-$0.17), with revenue of $61.08 million.
• A significant portion of OrthoPediatrics ownership is held by institutional investors, who own 69.05% of the company's stock.

Birchview Capital LP acquired a new stake in shares of OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 20,000 shares of the company's stock, valued at approximately $493,000. Birchview Capital LP owned approximately 0.08% of OrthoPediatrics at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. GAMMA Investing LLC raised its position in OrthoPediatrics by 4,618.2% in the 1st quarter. GAMMA Investing LLC now owns 10,616 shares of the company's stock valued at $261,000 after buying an additional 10,391 shares during the last quarter. SG Americas Securities LLC raised its position in OrthoPediatrics by 175.0% in the 1st quarter. SG Americas Securities LLC now owns 20,039 shares of the company's stock valued at $494,000 after buying an additional 12,753 shares during the last quarter. Dimensional Fund Advisors LP raised its position in OrthoPediatrics by 29.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 671,968 shares of the company's stock valued at $15,576,000 after buying an additional 152,681 shares during the last quarter. Invesco Ltd. raised its position in OrthoPediatrics by 12.1% in the 1st quarter. Invesco Ltd. now owns 18,349 shares of the company's stock valued at $452,000 after buying an additional 1,986 shares during the last quarter. Finally, Deutsche Bank AG raised its position in OrthoPediatrics by 57.1% in the 4th quarter. Deutsche Bank AG now owns 14,393 shares of the company's stock valued at $334,000 after buying an additional 5,233 shares during the last quarter. Institutional investors own 69.05% of the company's stock.

OrthoPediatrics Stock Up 1.0%

Shares of NASDAQ:KIDS traded up $0.20 during trading on Friday, hitting $20.91. 81,868 shares of the company were exchanged, compared to its average volume of 132,015. The stock has a market cap of $524.21 million, a price-to-earnings ratio of -11.68 and a beta of 1.06. OrthoPediatrics Corp. has a fifty-two week low of $16.59 and a fifty-two week high of $33.14. The firm has a fifty day moving average price of $21.09 and a two-hundred day moving average price of $21.97. The company has a current ratio of 6.66, a quick ratio of 3.43 and a debt-to-equity ratio of 0.27.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported ($0.11) earnings per share for the quarter, topping the consensus estimate of ($0.17) by $0.06. The firm had revenue of $61.08 million for the quarter, compared to analyst estimates of $61.40 million. OrthoPediatrics had a negative return on equity of 6.36% and a negative net margin of 18.92%. OrthoPediatrics has set its FY 2025 guidance at EPS. As a group, research analysts anticipate that OrthoPediatrics Corp. will post -0.93 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the company. Citigroup reissued a "market outperform" rating on shares of OrthoPediatrics in a research report on Friday, August 8th. JMP Securities set a $35.00 target price on OrthoPediatrics and gave the company a "market outperform" rating in a research report on Friday, August 8th. BTIG Research dropped their target price on OrthoPediatrics from $40.00 to $39.00 and set a "buy" rating on the stock in a research report on Wednesday, August 6th. Finally, Wall Street Zen raised OrthoPediatrics from a "sell" rating to a "hold" rating in a research report on Saturday, August 9th. Seven equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $34.14.

Insider Buying and Selling at OrthoPediatrics

In other OrthoPediatrics news, CFO Fred Hite bought 5,076 shares of the firm's stock in a transaction that occurred on Thursday, August 21st. The shares were acquired at an average cost of $19.41 per share, with a total value of $98,525.16. Following the acquisition, the chief financial officer owned 213,065 shares of the company's stock, valued at $4,135,591.65. The trade was a 2.44% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 31.80% of the company's stock.

OrthoPediatrics Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.